Compare Illumina, Inc. (ILMN) vs Lam Research Corporation (LRCX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Lam Research Corporation — how do they compare? Illumina, Inc. trades at $278.17 (market cap $39.95B), while Lam Research Corporation trades at $318.84 (market cap $401.19B). The key difference: Lam Research Corporation is far larger — about 10× Illumina, Inc.'s market cap, and Lam Research Corporation pays a 0.41% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 83 Days and Lam Research Corporation for 60 Days on average.
| ILMN | LRCX | |
|---|---|---|
Market Cap | $39.95B | $401.19B |
Volume | 3,169,503 | 8,960,892 |
Sector | Health | Technology |
52-Week High | $293.69 | $433.33 |
52-Week Low | $91.00 | $131.37 |
Typical Hold Time | 83 Days | 60 Days |
Enterprise Value | $41.31B | $399.35B |
Dividend Yield | — | 0.41% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $264.40, down 1.25% on the day but remains near its 52-week high of $278.99, reflecting strong momentum with a 94.9% YTD gain. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Fundamentals show a significant turnaround, with net income reaching $850 million in 2025 after prior losses, supported by robust gross margins of 66.38%. Technical indicators are bullish overall, with key support at $257 and resistance at $268.
The outlook for ILMN is positive, driven by earnings momentum, inclusion in the S&P 500, and strategic AI initiatives in genomics. However, risks include high valuation multiples, such as a P/E of 49.36, and potential margin pressure from cost volatility. Analyst consensus is bullish with a 54% buy rating, though the consensus price target of $241 suggests limited near-term upside from current levels.
Lam Research (LRCX) trades at $320.59, down 2.71% on the day, with a bearish technical signal but strong fundamentals. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 EPS expected at $2.18. Revenue grew to $18.44B in 2025, with a net income margin of 31.27%, while valuation ratios like P/E of 55.66 and P/S of 17.4 reflect high growth expectations. Analyst consensus is strongly bullish with a $375.68 price target, supported by AI-driven demand for semiconductor equipment.
The outlook for LRCX is positive due to robust earnings growth and strategic positioning in AI infrastructure, though risks include high valuation multiples and semiconductor cycle volatility. Upside potential exists if the company meets Q3 2026 earnings expectations and maintains margin expansion, but investors should monitor competitive pressures and macroeconomic factors affecting tech spending.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Lam Research Corporation
Lam Research manufactures equipment used to fabricate semiconductors. The firm is focused on the etching, deposition, and clean markets, which are key steps in the semiconductor manufacturing process, especially for 3D NAND flash storage, advanced DRAM, and leading-edge logic/foundry chipmakers. Lam's flagship Kiyo, Vector, and Sabre products are sold in all major geographies to key customers such as Samsung Electronics, Micron, Intel, and Taiwan Semiconductor Manufacturing.
Read more on LRCX →
